Molecular Characteristics and Prevalence of Viral Hepatitis E in Human Tissue and Cell Donors

ConditionHepatitis E

Trial statusRecruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexAll

AgeNot listed

SponsorUniversity Hospital Ostrava

About this trial

In this study, the researchers want to focus on the prevalence of anti-HEV antibodies by a new generation test, direct detection of HEV RNA, and its genotypic analysis in a group of human tissue and cell donors.

Eligibility criteria

Qualifiers

None

Disqualifiers

None

Trial design

Treatments tested in this trial

Elecsys Anti-HEV IgG, IgM

Treatment groups

300 Participants

are divided into 2 treatment groups

Sponsors and collaborators

University Hospital Ostrava

Lead sponsor

Source ClinicalTrials.gov